David Owens - 12 Sep 2025 Form 4 Insider Report for Nexalin Technology, Inc. (NXL)

Signature
/s/ David Owens Name: David Owens, M.D.
Issuer symbol
NXL
Transactions as of
12 Sep 2025
Net transactions value
$0
Form type
4
Filing time
12 Sep 2025, 17:08:34 UTC
Previous filing
27 Feb 2025
Next filing
30 Sep 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Owens David Chief Medical Officer, Director 4545 HARRIS TRAIL NW, ATLANTA /s/ David Owens Name: David Owens, M.D. 12 Sep 2025 0001916664

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NXL Stock Option (right to buy) Award $0 +203,125 +17% $0.000000 1,384,809 12 Sep 2025 Common Stock 203,125 $0.9600 Direct
transaction NXL Stock Option (right to buy) Award $0 +100,000 +7.2% $0.000000 1,484,809 12 Sep 2025 Common Stock 100,000 $0.9600 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.